ZA978842B - Use of an H<+>, K<+>-ATPase inhibitor in the treatment of nasal polyps. - Google Patents

Use of an H<+>, K<+>-ATPase inhibitor in the treatment of nasal polyps.

Info

Publication number
ZA978842B
ZA978842B ZA9708842A ZA978842A ZA978842B ZA 978842 B ZA978842 B ZA 978842B ZA 9708842 A ZA9708842 A ZA 9708842A ZA 978842 A ZA978842 A ZA 978842A ZA 978842 B ZA978842 B ZA 978842B
Authority
ZA
South Africa
Prior art keywords
treatment
nasal polyps
atpase inhibitor
atpase
inhibitor
Prior art date
Application number
ZA9708842A
Other languages
English (en)
Inventor
Per Lindberg
Jordi Serra-Carreras
Joan Pinas-Masso
Jan Trofast
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA978842B publication Critical patent/ZA978842B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
ZA9708842A 1996-10-11 1997-10-02 Use of an H<+>, K<+>-ATPase inhibitor in the treatment of nasal polyps. ZA978842B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603725A SE9603725D0 (sv) 1996-10-11 1996-10-11 New teatment

Publications (1)

Publication Number Publication Date
ZA978842B true ZA978842B (en) 1998-04-14

Family

ID=20404214

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9708842A ZA978842B (en) 1996-10-11 1997-10-02 Use of an H<+>, K<+>-ATPase inhibitor in the treatment of nasal polyps.

Country Status (34)

Country Link
EP (1) EP0946175B1 (ja)
JP (1) JP4100713B2 (ja)
KR (1) KR100510812B1 (ja)
CN (1) CN1146416C (ja)
AR (1) AR008886A1 (ja)
AT (1) ATE230597T1 (ja)
AU (1) AU738310B2 (ja)
BR (1) BR9711896A (ja)
CA (1) CA2268305C (ja)
CZ (1) CZ298799B6 (ja)
DE (1) DE69718347T2 (ja)
DK (1) DK0946175T3 (ja)
EE (1) EE04043B1 (ja)
ES (1) ES2188995T3 (ja)
HK (1) HK1022848A1 (ja)
HU (1) HUP0000036A3 (ja)
ID (1) ID23692A (ja)
IL (1) IL129324A0 (ja)
IS (1) IS1930B (ja)
MY (1) MY117918A (ja)
NO (1) NO321007B1 (ja)
NZ (1) NZ334786A (ja)
PL (1) PL190902B1 (ja)
PT (1) PT946175E (ja)
RS (1) RS49599B (ja)
RU (1) RU2197966C2 (ja)
SA (1) SA97180641B1 (ja)
SE (1) SE9603725D0 (ja)
SK (1) SK284252B6 (ja)
TR (1) TR199900770T2 (ja)
TW (1) TW568784B (ja)
UA (1) UA59374C2 (ja)
WO (1) WO1998016228A1 (ja)
ZA (1) ZA978842B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
TR200100560T2 (tr) 1998-08-18 2002-05-21 The Regents Of The University Of California EGF-R Antagonistlerinin uygulanmasıyla nefes yolunda mukus üretiminin önlenmesi
US6846799B1 (en) * 1998-08-18 2005-01-25 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
US7354894B2 (en) 1998-08-18 2008-04-08 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
AU2002342917A1 (en) * 2001-11-19 2003-06-10 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders
PL370839A1 (en) * 2002-03-14 2005-05-30 Altana Pharma Ag Use of proton pump inhibitors for the treatment of airway disorders
CN1652822A (zh) * 2002-05-07 2005-08-10 奥坦纳医药公司 用于治疗气道病症的可逆质子泵抑制剂和气道治疗剂的新组合
WO2003094968A2 (en) * 2002-05-07 2003-11-20 Altana Pharma Ag Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
PT1572217E (pt) 2002-12-12 2008-11-28 Nycomed Gmbh Medicamento combinado de r,r-formoterol e ciclesonida
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
PL1670482T5 (pl) 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN104408249B (zh) * 2014-11-24 2017-09-26 广州供电局有限公司 单芯电缆导体热性参数的确定方法及系统
KR101974504B1 (ko) * 2017-04-10 2019-05-03 재단법인 아산사회복지재단 호산구성 비용종 동물모델

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate

Also Published As

Publication number Publication date
IS1930B (is) 2004-05-18
CN1146416C (zh) 2004-04-21
MY117918A (en) 2004-08-30
DE69718347D1 (de) 2003-02-13
RU2197966C2 (ru) 2003-02-10
UA59374C2 (uk) 2003-09-15
JP4100713B2 (ja) 2008-06-11
ES2188995T3 (es) 2003-07-01
HU0000036D0 (ja) 2002-05-29
PL190902B1 (pl) 2006-02-28
SA97180641B1 (ar) 2005-12-18
TW568784B (en) 2004-01-01
IS5021A (is) 1999-04-08
NZ334786A (en) 2000-12-22
DE69718347T2 (de) 2003-08-28
ATE230597T1 (de) 2003-01-15
EP0946175B1 (en) 2003-01-08
YU16399A (sh) 2000-03-21
WO1998016228A1 (en) 1998-04-23
NO991619L (no) 1999-04-06
EP0946175A1 (en) 1999-10-06
CA2268305A1 (en) 1998-04-23
BR9711896A (pt) 1999-08-24
IL129324A0 (en) 2000-02-17
KR20000049046A (ko) 2000-07-25
HUP0000036A2 (hu) 2002-05-29
JP2001508034A (ja) 2001-06-19
SE9603725D0 (sv) 1996-10-11
SK284252B6 (sk) 2004-12-01
ID23692A (id) 2000-05-11
AU4640997A (en) 1998-05-11
NO991619D0 (no) 1999-04-06
DK0946175T3 (da) 2003-03-17
PL332692A1 (en) 1999-09-27
EE9900118A (et) 1999-10-15
CA2268305C (en) 2006-11-28
EE04043B1 (et) 2003-06-16
HK1022848A1 (en) 2000-08-25
KR100510812B1 (ko) 2005-08-31
CN1232397A (zh) 1999-10-20
SK38499A3 (en) 2000-03-13
NO321007B1 (no) 2006-02-27
CZ122999A3 (cs) 1999-09-15
RS49599B (sr) 2007-06-04
PT946175E (pt) 2003-04-30
TR199900770T2 (xx) 1999-06-21
AR008886A1 (es) 2000-02-23
AU738310B2 (en) 2001-09-13
HUP0000036A3 (en) 2003-02-28
CZ298799B6 (cs) 2008-02-06

Similar Documents

Publication Publication Date Title
ZA97631B (en) Migraine treatment.
SI1304327T1 (ja)
ID28981A (id) Turunan-turunan heksana 3-azabisiklo (3.1.0) yang berguna dalam terapi
ZA991951B (en) Compound and its use.
HK1019774A1 (en) Etching composition and use thereof.
ZA978842B (en) Use of an H&lt;+&gt;, K&lt;+&gt;-ATPase inhibitor in the treatment of nasal polyps.
ZA200007642B (en) Treatment of airborne microorganisms.
MXPA03002861A (es) Nuevos retinoides para tratamiento del enfisema.
ZA9811629B (en) The use of MMP inhibitors for the treatment of ocular angiogenesis.
ZA979731B (en) Treatment of asthma.
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
ZA200105690B (en) Novel treatment.
ZA978640B (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.
ZA972515B (en) Acne treatment.
Green Traditional norms of masculinity
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
MXPA03004017A (es) Metodo para el tratamiento de inflamacion.
ZA99253B (en) Treatment of waxes.
ZA200109120B (en) Use of Arylalkanoylpyridazines.
EP1032266A4 (en) USE OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION IN THE TREATMENT OF ARTHRITIS
ZA200007396B (en) Method of treatment.
AU4506499A (en) Novel 2,4-diaminophenol derivatives and the use thereof
AP2005003432A0 (en) Novel method of treatment.
AU5524399A (en) Inorgasmia treatment
ZA994585B (en) Treatment of water.